Fighting Seasonal Dryness

Your skin is not the only organ that needs extra moisture during the dry winter months.  Indoor heat and lack of humidity can also reek havoc on your eyes.  Dryness can cause discomfort and distortion.  At Price Vision Group we offer several products to help combat these problems. 

Dry eye sufferers experience abnormal tear film through the reduction of lipids, water, and mucin layers, and artificial tears can provide relief.  Oasis Tears and Oasis Tears Plus both contain glycerin, which works together with the water and lipids present in tear film and holds them on the surface of the cornea.  Blinking allows the solution to thin and spread, thus recoating the ocular surface and providing lasting comfort.  If artificial tears do not provide enough relief then a prescription product might be necessary.  Restasis® is an eye drop used to help increase the eyes’ natural ability to produce tears, which may be decreased because of inflammation due to dry eye. 

Sometimes drops are used in conjunction with supplements like HydroEye, a patented oral formulation that provides a blend of omega fatty acids, antioxidants and other nutrients which collectively maintain a healthy tear film and reduce inflammation.  And if HydroEye is not providing enough relief, Physician Recommended Nutriceuticals makes a formula for dry eye which combines highly refined and concentrated Omega-3 Essential Fatty Acids (EFAs) and vitamin D to both provide relief and support proper tear function. 

Contact Price Vision Group at 800-317-EYES for more information about these products.

Price Vision Group Welcomes Zachary Burkhart, M.D. and Matthew Feng, M.D.

Price Vision Group would like to welcome Drs. Zachary Burkhart and Matthew Feng to the Cornea Fellowship Program at Price Vision Group.  Dr. Burkhart received his undergraduate degree from the University of Notre Dame, then completed medical school at the University of Texas Southwestern Medical School at Dallas.  After a transitional internship at UT Medical Branch in Austin, he trained as an ophthalmology resident at the University of Texas at Houston.  Dr. Burkhart is interested in all anterior segment surgery, particularly corneal, cataract, and refractive surgery.

 Dr. Feng graduated magna cum laude from Harvard College and was a Dean’s Merit Scholar at the University of Pittsburgh School of Medicine.  As a resident at the University of Arizona, he became interested in corneal surgery and has published research on corneal imaging for pre-LASIK screening.  His hobbies include nature photography, travel, and in-line skating. 

 We are happy to have them as part of the Price Vision Group team and look forward to working with them this year. 

Contact Price Vision Group at 800-317-EYES for more information.

Meet Dr. McKee – The Newest Member of the Price Vision Group Team

Yuri McKee, M.D. is a Board Certified Ophthalmic Surgeon with fellowship training in Corneal and Refractive Surgery.  His clinical and surgical training in corneal disease, complex anterior segment surgery, and refractive surgery was completed at the renowned Emory Eye Center in Atlanta, GA.  Dr McKee worked as the corneal specialist for private group practice in Atlanta prior to joining Price Vision Group.  During this time he specialized exclusively in advanced corneal transplant techniques, premium cataract surgery, anterior segment reconstruction, and refractive surgery.  His background includes a BA in Psychology from Minnesota State University, a Master’s Thesis in developmental neurobiology, and an MD from Loma Linda University in CA.  Dr. McKee completed his his surgical internship at the University of Minnesota.  He received the Outstanding Graduating Resident Award at the Louisiana State University/Ochsner Clinic Foundation Ophthalmology Residency where he trained in the clinical and surgical subspecialties of ophthalmology.  Dr McKee was also recognized with an award for ranking in the top 5th percentile in the nation for his score on the annual ophthalmology in-service exam.  He performed similarly on the American Board of Ophthalmology certification examination.  As a resident he received a research scholarship with which he developed a novel sustained ocular surface drug delivery system.  He was recently granted a US patent on the technique.

Prior to his training in Ophthalmology Dr. McKee served for six years as an active duty US Air Force flight surgeon where he attained the rank of Major.  During this time, he was the medical director of the Aerospace Medicine Clinic and the course director of Top Knife II USAF Flight Surgeon High Performance Aircraft Course at Luke AFB, AZ. He also served as primary care, aviation medicine specialist, and hyperbaric specialist for the largest training base in the US Air Force.  Prior to this Dr McKee was stationed in Okinawa, Japan for four years where he served in a combat-ready F-15 Eagle squadron.  Dr McKee was deployed twice in support of Operation Enduring Freedom where he logged numerous combat flight hours in both air superiority and combat search and rescue missions.  His commitment to service was recognized with numerous military medals and awards, including a Command Flight Surgeon of the Year distinction. 

Dr. McKee is a native of Minnesota.  He is married with two children.  He enjoys flying, scuba diving, and international travel.  Most of all Dr McKee values time spent with his family.

Contact Price Vision Group at 800-317-EYES to for more information.

Price Vision Group Welcomes Yuri McKee, M.D.

Price Vision Group has added a new physician to the practice.  Dr. McKee is a Board Certified Ophthalmic Surgeon with fellowship training in Corneal and Refractive Surgery.  His clinical and surgical training in corneal disease, complex anterior segment surgery, and refractive surgery was completed at the renowned Emory Eye Center in Atlanta, GA. Dr McKee worked as the corneal specialist for private group practice in Atlanta prior to joining Price Vision Group.  During this time he specialized exclusively in advanced corneal transplant techniques, premium cataract surgery, anterior segment reconstruction, and refractive surgery.  His background includes a BA in Psychology from Minnesota State University, a Master’s Thesis in developmental neurobiology, and an MD from Loma Linda University in CA.  Dr. McKee completed his surgical internship at the University of Minnesota.  He received the Outstanding Graduating Resident Award at the Louisiana State University/Ochsner Clinic Foundation Ophthalmology Residency where he trained in the clinical and surgical subspecialties of ophthalmology.  Dr McKee was also recognized with an award for ranking in the top 5th percentile in the nation for his score on the annual ophthalmology in-service exam.  He performed similarly on the American Board of Ophthalmology certification examination.  As a resident he received a research scholarship with which he developed a novel sustained ocular surface drug delivery system.  He was recently granted a US patent on the technique.

Prior to his training in Ophthalmology Dr. McKee served for six years as an active duty US Air Force flight surgeon where he attained the rank of Major.  During this time, he was the medical director of the Aerospace Medicine Clinic and the course director of Top Knife II USAF Flight Surgeon High Performance Aircraft Course at Luke AFB, AZ. He also served as primary care, aviation medicine specialist, and hyperbaric specialist for the largest training base in the US Air Force.  Prior to this Dr McKee was stationed in Okinawa, Japan for four years where he served in a combat-ready F-15 Eagle squadron.  Dr McKee was deployed twice in support of Operation Enduring Freedom where he logged numerous combat flight hours in both air superiority and combat search and rescue missions.  His commitment to service was recognized with numerous military medals and awards, including a Command Flight Surgeon of the Year distinction. 

Dr. McKee is a native of Minnesota.  He is married with two children.  He enjoys flying, scuba diving, and international travel.  Most of all Dr McKee values time spent with his family.

Contact Price Vision Group at 800-317-EYES to for more information, or to schedule an exam.

Price Vision Group Adopts New Technology for Improved Dry Eye Treatment

One of the most common clinical challenges faced in optometry is dry eye, and the doctors at Price Vision Group have extensive experience in the diagnosis and treatment of dry eye disease.  Price Vision Group is keeping up with the latest technology regarding dry eyes and was recently certified by TearLab as an “AccreditedDryEyeCenter”. This system affords them the ability to measure tear osmolarity with the TearLab test, which helps diagnose, treat, and monitor a patient’s dry eyes.  Treatment is prescribed based on the measurements from the TearLab. Treatments range from Omega 3 supplements, tear replacement drops, punctal plugs, anti- inflammatory drops, oral antibiotics and prescription strength artificial tears.

 By being one of the first practices in the state of Indianato be certified as an Accredited Dry Eye Center, Price Vision Group has demonstrated expertise and dedication to the most advanced technologies and treatments in the management of dry eye disease.

Contact Price Vision Group at 800-317-EYES to for more information about dry eye symptoms and treatments.

The Optomap System assists in Improved Retinal Health

The retina refers to the lining in the back of the eye that receives light through the lens and transmits an image to the brain, enabling site.  Because the retina is so crucial in providing vision, it is important that it be monitored regularly.  While eye conditions such as glaucoma and macular degeneration can be detected through a retinal exam, signs of other conditions like diabetes, hypertension, and heart disease can also be identified.  However, traditionally the retinal is viewed through the pupil manually, limiting the area visible and leaving no digital record and no way for the patient to observe results.  However, Price Vision Group is proud to have recently adopted the optomap system.  This is an ultra-wide digital retinal imaging system that provides a panoramic view of more than 80% of the retina and thus allows doctors a better chance of early detection and treatment of diseases.  It also allows for the patient to better understand abnormalities because the optomap system allows them to see their own retina, which was previously only available through a specialist. 

Contact Price Vision Group at 800-317-EYES to for more information about the optomap system.

Why is corneal thickness important when considering LASIK?

The thickness of the cornea is one of the major factors in determining if LASIK is the most appropriate refractive surgery for an individual.  During LASIK a flap is cut on the surface of the cornea.  The flap is peeled back, and a laser reshapes the cornea by removing tissue before the flap is laid back down.  The amount of tissue removed is determined by the prescription power being corrected, thus someone who is more myopic would require more tissue removed.  A certain amount of corneal bed thickness must be maintained to prevent an increased risk of post-surgery complications such as corneal ectasia.  However, just because one doctor feels a patient has corneas that are too thin to safely undergo LASIK does not mean that would be the consensus among all doctors.  Experienced surgeons using advanced equipment might be able to perform LASIK on a patient who was denied by another physician.  And conversely, one doctor might recommend LASIK where another would not.  For this reason, it is important to visit a reputable doctor, and in some cases, seek several opinions before proceeding with a refractive surgery. 

Contact Price Vision Group at 800-317-EYES to for more information about LASIK and other refractive surgery options.

Meet Dr. Schroeder

 

Anne Schroeder, MD is a graduate of The University of  Chicago and The Chicago Medical School, with honors. She completed her ophthalmology training at the Havener Eye Institute at Ohio State University, where she was an active member of the Resident  Advisory Council and performed research in the areas of glaucoma and retina.  Following graduation, Dr. Schroeder joined a Mt. Sinai affiliated practice in New York where she combined academics and community practice in a caring and compassionate manner. 

 Joining Price Vision Group in  Spring 2011, Dr. Schroeder comprehensively   evaluates and treats corneal and cataract patients.  When asked what she      enjoys about being a part of the practice Dr. Schroder said, “I believe that       educating patients is truly a great privilege. At Price Vision Group, I have the   opportunity to do just that —all while providing thorough care and being part of a dynamic team committed to improving the vision of our patients.”

Contact Price Vision Group at 800-317-EYES for more information about the practice. 

 

Pentacam Study

Cornea Research Foundation of America received a $5000 grant from the American Society of Cataract and Refractive Surgery Foundation to study whether the Pentacam can provide a more accurate way to screen patients before refractive surgery and better predict who is a poor candidate and likely to experience ectasia.

This study, conducted by Frederico Guerra, M.D., researach fellow for the Cornea Research Foundation, is beneficial because it can lead to more precise refractive screening methods that will help prevent falsely excluding eligible candidates, and also avoid missing patients who are prone to develop problems. As part of the study we are inviting people who had LASIK at Price Vision Group between 1 and 3 years ago to come back for a free eye exam to evaluate their overall eye health and to gain necessary data for the study.

Contact Price Vision Group at 800-317-EYES to learn more about this study.

Cross-linking Study

Dr. Price has received approval to conduct a study of cross-linking to treat keratoconus or ectasia. This treatment involves instilling eye drops containing riboflavin (also known as vitamin B2) into your eye and then shining a special light on your eye for 30 minutes to strengthen the cornea. Because patients with keratoconus must show that their condition has progressed in the last 24 months, it may be necessary for us to get some information about your eyes from your regular eye doctor. The best candidates for this procedure are individuals who are actively progressing and are concerned that their condition may get worse and who want to avoid a corneal transplant. Although some patients have experienced improved vision from the cross linking procedure, this should not be a patient’s primary goal for treatment. Those interested in the study would be required to undergo a screening to determine if they are a candidate, and then patients will be seen 1 day, 1 week, 3 months, and 6 months after the procedure.

Contact Price Vision Group at 800-317-EYES to learn more about this study.